JP6966667B2 - ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物 - Google Patents

ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物 Download PDF

Info

Publication number
JP6966667B2
JP6966667B2 JP2021521065A JP2021521065A JP6966667B2 JP 6966667 B2 JP6966667 B2 JP 6966667B2 JP 2021521065 A JP2021521065 A JP 2021521065A JP 2021521065 A JP2021521065 A JP 2021521065A JP 6966667 B2 JP6966667 B2 JP 6966667B2
Authority
JP
Japan
Prior art keywords
aqueous ophthalmic
ophthalmic composition
diquafosol
polyvinylpyrrolidone
eye
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021521065A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021039748A1 (ja
Inventor
健司 森島
博之 浅田
雄介 桃川
明日香 神村
健一 遠藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of JPWO2021039748A1 publication Critical patent/JPWO2021039748A1/ja
Priority to JP2021171358A priority Critical patent/JP7614069B2/ja
Application granted granted Critical
Publication of JP6966667B2 publication Critical patent/JP6966667B2/ja
Priority to JP2024228577A priority patent/JP7902251B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2021521065A 2019-08-27 2020-08-25 ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物 Active JP6966667B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2021171358A JP7614069B2 (ja) 2019-08-27 2021-10-20 ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物
JP2024228577A JP7902251B2 (ja) 2019-08-27 2024-12-25 ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019154525 2019-08-27
JP2019154525 2019-08-27
PCT/JP2020/031917 WO2021039748A1 (ja) 2019-08-27 2020-08-25 ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021171358A Division JP7614069B2 (ja) 2019-08-27 2021-10-20 ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物

Publications (2)

Publication Number Publication Date
JPWO2021039748A1 JPWO2021039748A1 (ja) 2021-09-30
JP6966667B2 true JP6966667B2 (ja) 2021-11-17

Family

ID=74685901

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2021521065A Active JP6966667B2 (ja) 2019-08-27 2020-08-25 ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物
JP2021171358A Active JP7614069B2 (ja) 2019-08-27 2021-10-20 ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物
JP2024228577A Active JP7902251B2 (ja) 2019-08-27 2024-12-25 ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021171358A Active JP7614069B2 (ja) 2019-08-27 2021-10-20 ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物
JP2024228577A Active JP7902251B2 (ja) 2019-08-27 2024-12-25 ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物

Country Status (7)

Country Link
JP (3) JP6966667B2 (enExample)
KR (2) KR102656181B1 (enExample)
CN (2) CN114286670B (enExample)
MY (1) MY209059A (enExample)
PH (1) PH12022550474A1 (enExample)
TW (1) TWI848171B (enExample)
WO (1) WO2021039748A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025031918A (ja) * 2019-08-27 2025-03-07 参天製薬株式会社 ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202007977RA (en) * 2018-02-28 2020-09-29 Santen Pharmaceutical Co Ltd Ophthalmic composition comprising diquafosol and cationic polymer
JP7175431B1 (ja) 2021-03-30 2022-11-18 千寿製薬株式会社 ヘテロシクリデンアセトアミド誘導体含有懸濁液
CN114646705A (zh) * 2022-03-22 2022-06-21 武汉绿合医药科技有限公司 一种地夸磷索钠滴眼液有关物质含量检测方法
JP2024043685A (ja) * 2022-09-20 2024-04-02 参天製薬株式会社 ジクアホソルまたはその塩を含有する眼科用組成物のｐＨの低下を抑制する方法
JP7245383B1 (ja) 2022-09-20 2023-03-23 参天製薬株式会社 ジクアホソルまたはその塩を含有する眼科用組成物のｐＨの低下を抑制する方法
KR20250160050A (ko) 2024-05-03 2025-11-11 삼천당제약주식회사 물리화학적 특성이 개선된 안구건조증 예방 또는 치료용 약학 조성물
CN119970633A (zh) * 2025-03-26 2025-05-13 苏州乐珠制药有限公司 一种地夸磷索钠滴眼液及其制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0365270A (ja) 1989-07-31 1991-03-20 Kanzaki Paper Mfg Co Ltd 塗布シートの製造方法
JPH0365270U (enExample) 1989-10-31 1991-06-25
US5358706A (en) * 1992-09-30 1994-10-25 Union Carbide Chemicals & Plastics Technology Corporation Muco-adhesive polymers
CA2125060C (en) * 1993-07-02 1999-03-30 Henry P. Dabrowski Ophthalmic solution for artificial tears
US5422116A (en) * 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system
KR100549904B1 (ko) * 1996-03-27 2006-05-16 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 우리딘트리포스페이트및관련화합물을함유하는섬모운동장해치료용약학조성물
US5900407A (en) * 1997-02-06 1999-05-04 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with uridine triphosphates and related compounds
US6274626B1 (en) * 1998-12-22 2001-08-14 Bausch & Lomb Incorporated Pheniramine-containing compositions and method for treating allergic responses
WO2001047532A1 (en) * 1999-12-27 2001-07-05 Santen Pharmaceutical Co., Ltd. System for stabilizing lacrimal fluid layer
AU2001260643B9 (en) * 2000-05-30 2006-10-19 Merck Sharp & Dohme Corp. Ectocornea extension promoters
KR101389300B1 (ko) * 2005-02-14 2014-04-25 존슨 앤드 존슨 비젼 케어, 인코포레이티드 안과용 렌즈의 제조방법, 안과용 장치 및 콘택트 렌즈
CA2810481C (en) * 2010-09-10 2018-06-19 Santen Pharmaceutical Co., Ltd. Agent for treatment of dry eye characterized by combining p2y2 receptor agonist and hyaluronic acid or salt thereof, method for treating dry eye, and use of the p2y2 receptor agonist and hyaluronic acid or salt thereof
US20110052678A1 (en) * 2010-11-05 2011-03-03 Shantha Totada R Method for treating age related macular degeneration
AU2011350762B2 (en) * 2010-12-28 2017-04-06 Santen Pharmaceutical Co., Ltd. Ophthalmic solution containing diquafosol, method for producing same, and method for preventing formation of insoluble precipitate
KR20120077080A (ko) 2010-12-30 2012-07-10 동우 화인켐 주식회사 광학필름 및 이를 이용한 백라이트 유닛
US20160213708A1 (en) * 2012-01-08 2016-07-28 Medicure Technologies Ltd. Ophthalmic composition
MY169816A (en) * 2012-03-26 2019-05-16 Santen Pharmaceutical Co Ltd Ophthalmic solution comprising diquafosol
JP2015032653A (ja) 2013-08-01 2015-02-16 株式会社東芝 固体撮像装置
JP6267003B2 (ja) 2014-02-27 2018-01-24 参天製薬株式会社 ジクアホソルまたはその塩およびレバミピドまたはその塩を組み合わせたことを特徴とする涙液分泌促進剤
EP3139903B1 (en) * 2014-05-07 2019-07-03 Croma-Pharma Gesellschaft m.b.H. Aqueous ophthalmic solution and method for treating dry eye syndrome
EA034517B1 (ru) * 2014-12-25 2020-02-17 Сантен Фармасьютикал Ко., Лтд. Водный офтальмологический раствор
WO2016195072A1 (ja) * 2015-06-05 2016-12-08 参天製薬株式会社 ソフトコンタクトレンズが装用されたドライアイ患者の眼に点眼されるように用いられることを特徴とするドライアイ治療剤
CN107837276A (zh) * 2016-09-19 2018-03-27 刘力 局部给药的药物组合物
SG11202007977RA (en) * 2018-02-28 2020-09-29 Santen Pharmaceutical Co Ltd Ophthalmic composition comprising diquafosol and cationic polymer
JP6966667B2 (ja) * 2019-08-27 2021-11-17 参天製薬株式会社 ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025031918A (ja) * 2019-08-27 2025-03-07 参天製薬株式会社 ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物
JP7902251B2 (ja) 2019-08-27 2026-08-07 参天製薬株式会社 ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物

Also Published As

Publication number Publication date
WO2021039748A1 (ja) 2021-03-04
KR20220052971A (ko) 2022-04-28
MY209059A (en) 2025-06-18
JP2025031918A (ja) 2025-03-07
JPWO2021039748A1 (ja) 2021-09-30
JP2022003099A (ja) 2022-01-11
CN117771172A (zh) 2024-03-29
KR102656181B1 (ko) 2024-04-08
PH12022550474A1 (en) 2023-03-06
TWI848171B (zh) 2024-07-11
JP7902251B2 (ja) 2026-08-07
TW202122094A (zh) 2021-06-16
CN114286670A (zh) 2022-04-05
JP7614069B2 (ja) 2025-01-15
KR20240049646A (ko) 2024-04-16
CN114286670B (zh) 2024-01-16

Similar Documents

Publication Publication Date Title
JP7614069B2 (ja) ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物
JP7472202B2 (ja) ジクアホソルおよびカチオン性ポリマーを含有する眼科用組成物
JP7824362B2 (ja) ジクアホソルまたはその塩、ビニル系高分子およびセルロース系高分子を含有する眼科用組成物
CN110913867B (zh) 热凝胶化人工泪液
HK40065412B (en) Diquafosol or salt thereof, and aqueous ophthalmic composition containing polyvinylpyrrolidone
HK40065412A (en) Diquafosol or salt thereof, and aqueous ophthalmic composition containing polyvinylpyrrolidone
HK40037570A (en) Ophthalmic composition comprising diquafosol and cationic polymer
HK40037570B (en) Ophthalmic composition comprising diquafosol and cationic polymer

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210415

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210415

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20210415

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210420

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210720

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210827

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210921

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20211021

R150 Certificate of patent or registration of utility model

Ref document number: 6966667

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R153 Grant of patent term extension

Free format text: JAPANESE INTERMEDIATE CODE: R153

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250